This issue of Vital Signs, released on August 20, 2007, provides an investigation of new challenges and issues that manufacturers must consider when strategizing the marketing and design of new therapeutic products in the healthcare industry. Additionally, a company spotlight is provided for Proteus Biomedical, a developer of intelligent medicine products. Reimbursement and regulatory news from the FDA is also provided for the week of August 6 - August 10, 2007.

This issue of Vital Signs, released on August 20, 2007, provides an investigation of new challenges and issues that manufacturers must consider when strategizing the marketing and design of new therapeutic products in the healthcare industry. Additionally, a company spotlight is provided for Proteus Biomedical, a developer of intelligent medicine products. Reimbursement and regulatory news from the FDA is also provided for the week of August 6 - August 10, 2007. Read Less